Elizabeth Weber

1.2k total citations
32 papers, 643 citations indexed

About

Elizabeth Weber is a scholar working on Pharmacology, Dermatology and Oncology. According to data from OpenAlex, Elizabeth Weber has authored 32 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Dermatology and 10 papers in Oncology. Recurrent topics in Elizabeth Weber's work include Drug-Induced Adverse Reactions (14 papers), CAR-T cell therapy research (10 papers) and Contact Dermatitis and Allergies (9 papers). Elizabeth Weber is often cited by papers focused on Drug-Induced Adverse Reactions (14 papers), CAR-T cell therapy research (10 papers) and Contact Dermatitis and Allergies (9 papers). Elizabeth Weber collaborates with scholars based in Canada, United States and United Kingdom. Elizabeth Weber's co-authors include Simon R. Knowles, Neil H. Shear, Jerome A. Leis, Nick Daneman, Derek R. MacFadden, Ilana Saltzman, Wayne L. Gold, Ibrahim S. Al‐Busaidi, Nisha Andany and Jordan Tarshis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Elizabeth Weber

32 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Weber Canada 14 411 188 161 74 71 32 643
Adile Berna Dursun Türkiye 18 471 1.1× 140 0.7× 198 1.2× 71 1.0× 119 1.7× 53 962
Mona Al‐Ahmad Kuwait 14 85 0.2× 96 0.5× 242 1.5× 10 0.1× 29 0.4× 83 713
Alexander M. Cartron United States 10 30 0.1× 147 0.8× 34 0.2× 5 0.1× 15 0.2× 34 344
Suk Joong Yong South Korea 9 26 0.1× 30 0.2× 21 0.1× 6 0.1× 33 0.5× 27 394
Jennifer A. Namazy United States 14 48 0.1× 35 0.2× 135 0.8× 6 0.1× 4 0.1× 41 838
Myoung Kyu Lee South Korea 13 25 0.1× 23 0.1× 20 0.1× 6 0.1× 47 0.7× 35 477
M Scherrer Switzerland 12 20 0.0× 52 0.3× 36 0.2× 4 0.1× 12 0.2× 101 604
Xavier Jaumont Switzerland 13 18 0.0× 114 0.6× 248 1.5× 2 0.0× 28 0.4× 22 789
Noah Agada United States 10 16 0.0× 161 0.9× 9 0.1× 9 0.1× 19 0.3× 20 431
James Herman United States 10 21 0.1× 64 0.3× 63 0.4× 20 0.3× 17 388

Countries citing papers authored by Elizabeth Weber

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Weber more than expected).

Fields of papers citing papers by Elizabeth Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Weber. The network helps show where Elizabeth Weber may publish in the future.

Co-authorship network of co-authors of Elizabeth Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Weber. A scholar is included among the top collaborators of Elizabeth Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Weber. Elizabeth Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chong, Elise A., Sunita D. Nasta, Daniel J. Landsburg, et al.. (2024). Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma. Transplantation and Cellular Therapy. 30(7). 726.e1–726.e8. 4 indexed citations
2.
Landsburg, Daniel J., Sunita D. Nasta, Jakub Svoboda, et al.. (2023). Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T Cells. Transplantation and Cellular Therapy. 29(8). 495–503. 3 indexed citations
3.
Landsburg, Daniel J., Sunita D. Nasta, Jakub Svoboda, et al.. (2023). Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions. Blood. 142(Supplement 1). 2341–2341. 1 indexed citations
4.
Nasta, Sunita D., Mitchell E. Hughes, Alfred L. Garfall, et al.. (2022). Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting. Clinical Lymphoma Myeloma & Leukemia. 22(8). e730–e737. 11 indexed citations
5.
Weber, Elizabeth, et al.. (2021). Tisagenlecleucel Therapy: Nursing Considerations for the Outpatient Setting. Seminars in Oncology Nursing. 37(4). 151178–151178. 14 indexed citations
6.
Vorobeichik, Leon, Elizabeth Weber, & Jordan Tarshis. (2018). Misconceptions Surrounding Penicillin Allergy: Implications for Anesthesiologists. Anesthesia & Analgesia. 127(3). 642–649. 38 indexed citations
7.
Leis, Jerome A., Lesley Palmay, Sumit Raybardhan, et al.. (2017). Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation. Clinical Infectious Diseases. 65(7). 1059–1065. 45 indexed citations
8.
Corbo, M, Elizabeth Weber, & Joel G. DeKoven. (2016). Lidocaine Allergy: Do Positive Patch Results Restrict Future Use?. Dermatitis. 27(2). 68–71. 11 indexed citations
9.
MacFadden, Derek R., Wayne L. Gold, Nick Daneman, et al.. (2016). Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases. 63(7). 904–910. 201 indexed citations
10.
Somech, Raz, Elizabeth Weber, & Sasson Lavi. (2009). Evaluation of Immediate Allergic Reactions to Cephalosporins in Non-Penicillin-Allergic Patients. International Archives of Allergy and Immunology. 150(3). 205–209. 17 indexed citations
11.
Weber, Elizabeth. (2007). The Duk-Duks: Primitive and Historic Types of Citizenship. Internet Archive (Internet Archive). 1 indexed citations
12.
Knowles, Simon R., et al.. (2006). Povidone‐Iodine–Induced Burn: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1641–1645. 31 indexed citations
13.
Phillips, Elizabeth J., et al.. (2005). Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis. 53(6). 335–338. 21 indexed citations
14.
Shapiro, Lori E., Simon R. Knowles, Elizabeth Weber, Manuela G. Neuman, & Neil H. Shear. (2003). Safety of Celecoxib in Individuals Allergic to Sulfonamide. Drug Safety. 26(3). 187–195. 36 indexed citations
15.
Binkley, Karen, et al.. (2002). Allergic anaphylaxis to Laminaria. Allergy. 57(4). 370–370. 31 indexed citations
16.
Phillips, Elizabeth J., Simon R. Knowles, Elizabeth Weber, & D. Blackburn. (2001). Cephalexin tolerated despite delayed aminopenicillin reactions. Allergy. 56(8). 790–790. 20 indexed citations
17.
Knowles, Simon R. & Elizabeth Weber. (1998). Dextromethorphan anaphylaxis. Journal of Allergy and Clinical Immunology. 102(2). 316–317. 9 indexed citations
18.
Weber, Elizabeth. (1998). Intrathecal addition of morphine to bupivacaine is not the cause of postoperative nausea and vomiting. Regional Anesthesia & Pain Medicine. 23(1). 81–86. 15 indexed citations
19.
Weber, Elizabeth. (1996). Cefazolin specific side chain hypersensitivity. Journal of Allergy and Clinical Immunology. 98(4). 849–850. 17 indexed citations
20.
Zimmerman, Barry J. & Elizabeth Weber. (1985). Candida and "20th-century disease".. PubMed. 133(10). 965–6. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026